Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 25.02
0.00 (0.00%)
Jul 30, 2026, 3:40 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 8.79 billion as of July 29, 2026. Its market cap has decreased by -61.92% in one year.
Market Cap
8.79B
Enterprise Value
6.78B
Revenue
1.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
25.02
ChartMarket Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 8.79B, a decrease of -57.39%. That is a compound annual growth rate of -13.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 8.79B | -32.69% |
| Dec 31, 2025 | 13.06B | -16.21% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenFleet Therapeutics (Shanghai) | 10.66B |
| Nanjing Leads Biolabs | 10.26B |
| Ascletis Pharma | 9.49B |
| Shaanxi Micot Pharmaceutical Technology | 9.34B |
| TenNor Therapeutics (Suzhou) | 8.78B |
| Suzhou Ribo Life Science | 8.51B |
| Lepu Biopharma | 8.16B |
| CARsgen Therapeutics Holdings | 7.84B |